Educational research & price index · Independent Janoshik & MZ Biolabs COA verification
Guide|10 CitationsCognitive & Sleep

Dihexa Dosing Protocol: Neurotrophic Peptide Guide

Also known as: PNB-0408, HGF / c-Met Synaptogenic Hexapeptide

Dose Range
0.1–1 mgResearch range
0Typical research window: 0.1–1 mg1.5 mg

Studied in published research — not a medical recommendation. Primary protocol (Cognitive Enhancement Protocol): 0.1-1.0 mg/kg, Daily.

Protocol at a Glance
How Often
Daily

Daily

A Typical Run
2-4 weeks

Research-reported range; the linked study used a different dose or units. Animal studies showed dose-dependent cognitive enhancement

How It's Taken
Vial

Subcutaneous extrapolated

Evidence
Clinical Trials

Published peer-reviewed research & clinical protocols

Half-Life & 72-Hour Clearance Shape
Not established

No verified human half-life on file for this compound

0h18h36h54h72h
On Your SyringeU-100 Insulin Syringe

A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.

5 mg vial · 2 mL water · 0.5 mL syringe
Concentration: 2.5 mg in every mL (25 mcg per unit)
0u10u20u30u40u50u
Low end: 0.1 mg4 units
High end: 1 mg40 units

All U-100: 100 units = 1 mL. 50 doses in the vial at the low end (5 doses at the high end).

Track the doses you run

Save Dihexa to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.

Verified Peptide Vial Suppliers · Sorted by Real $/mg•Checked Nov 11, 2026

Dihexa supplier & $/mg comparison.

Source:
Max $/mg:
Sort:
Pure Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026); code PEPTIDE9544 takes 10% off at checkout
$42.00
10mg vial
$4.20/mg
Elite Research USA
Batch COA on product page
US Domestic Vial
List price
$175.00
10mg vial
$17.50/mg
Sorted strictly by calculated $/mg or 2026 COA score. Only research peptide vial suppliers are included in $/mg benchmarks.
Full Verified $/mg Index →

At a Glance · 2026 FDA / 503A / WADA / Evidence Profile

2026 FDA 503A Cat-2 UpdateTier 3 — Translational Animal & Clinical Obs
Pharmacological Class
Neurotrophic & Neuroregulatory Neuropeptide (BDNF / NGF / GABA Modulator)
Administration Route
Under-the-skin injection (Subcutaneous extrapolated)
2026 FDA & 503A Status
Not FDA-approved. In April 2026, the FDA removed 14 peptides (including BPC-157, Thymosin Beta-4/TB-500, CJC-1295, Ipamorelin, AOD-9604, Semax, Selank, and DSIP) from the Category 2 503A Interim Bulks List pending formal July 2026 PCAC rulemaking. Available as COA-verified research reference standards or via specialized physician telehealth guidance.
WADA Sport Status
Prohibited at All Times (WADA S0 Unapproved Substances & S2.2 Peptide Hormones, Growth Factors & Mimetics)
Evidence Tier
Tier 3 — Translational Animal & Clinical Obs: Replicated mammalian preclinical models plus extensive off-label physician & community protocol tracking
What is a Nootropic Peptide?

A peptide that enhances cognitive function — memory, focus, learning, or neuroprotection. Unlike synthetic nootropics (racetams, modafinil), peptide nootropics work through neurotrophic factors like BDNF and NGF. Examples: Semax, Selank, Dihexa, PE-22-28. Most were developed in Russian neuroscience labs.

Bottom Line Up Front

Dihexa is a nootropic peptide developed at Washington State University. It is a hepatocyte growth factor (HGF) activator and is 7 orders of magnitude more potent than BDNF in synaptogenesis assays. Very limited human data.

Best evidence for

Synaptogenesis, cognitive enhancement (cell/animal data)

Weakest evidence for

Human cognitive enhancement, Alzheimer's treatment

Pharma equivalent

None

Studies on file

10 (7 human)

EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. Dihexa is not FDA approved for human use (unless specified above). This information does not constitute medical advice.

Overview

Dihexa is a synthetic peptide derived from angiotensin IV that was developed at Washington State University. It is a potent hepatocyte growth factor (HGF) activator and has shown remarkable cognitive enhancement in animal models of Alzheimer's disease.

Mechanisms of Action

  • Activates hepatocyte growth factor (HGF) via c-Met receptor
  • Stimulates synaptogenesis and dendritic arborization
  • Crosses blood-brain barrier effectively
  • Activates PI3K/AKT signaling pathway

Research Protocols

Summaries of published research. For educational purposes only.

Protocol NameSourceDoseFrequencyDurationRouteEvidenceLinkSave
Cognitive Enhancement Protocol
animal study
0.1-1.0 mg/kgDaily2-4 weeksSubcutaneous extrapolatedanimal
Baseline & Mid-Cycle Biomarker Bloodwork Panel

Systemic Inflammation, Tissue Repair & Immune Biomarker Panel (Dihexa)

Objective inflammatory, hematologic, and trace-mineral markers to quantify connective-tissue recovery, cytokine resolution, and organ safety.

Draw fasted morning labs at Baseline (Day 0) and Mid-Cycle (Week 6–8)

hs-CRP (High-Sensitivity C-Reactive Protein)

Day 0 + Wk 6–8

Why track at baseline: Quantifies baseline systemic IL-6/NF-κB inflammatory burden from tendon, joint, gut, or vascular injury.

Week 6–8 check: Target <1.0 mg/L (optimal <0.5 mg/L) by Week 6–8 as tissue inflammation resolves.

ESR (Sedimentation Rate) & Ferritin

Day 0 + Wk 6–8

Why track at baseline: Tracks chronic connective-tissue and autoimmune/mucosal inflammatory activity alongside iron stores.

Week 6–8 check: Downward trend in ESR confirming structural resolution rather than temporary analgesic masking.

CBC with Differential (WBC, Neutrophil/Lymphocyte Ratio)

Day 0 + Wk 6–8

Why track at baseline: Evaluates innate/adaptive immune balance (especially for Thymosin Alpha-1, Thymosin Beta-4, LL-37 & KPV).

Week 6–8 check: Balanced lymphocyte count and improved Neutrophil-to-Lymphocyte Ratio (NLR 1.2–2.0).

CMP (Liver/Kidney) + Serum Copper & Zinc Ratio

Day 0 + Wk 6–8

Why track at baseline: Verifies baseline hepatic/renal function and checks Copper:Zinc balance before GHK-Cu / GLOW / KLOW protocols.

Week 6–8 check: Maintain 1:1 to 1.2:1 Zinc-to-Copper equilibrium and normal transaminases/creatinine.

Test before and during your protocol: one baseline panel of 100+ Quest biomarkers covering the markers above, plus a mid-cycle retest. No doctor visit required.Code SPAMBASSADOR
Get baseline bloodwork at Superpower

Related Studies

7 Human3 Animal

Although preclinical studies are promising, there is a current lack of clinical trials. This review integrates current mechanistic insights with orthopaedic relevance, emphasizing safety, efficacy, and future directions for responsible integration into musculoskeletal care.

Limitations: No placebo control reported. Review article — no new primary data.

2026|Journal of the American Academy of Orthopaedic Surgeons. Global research &amp; reviews
PubMed

Exposure to 3-NP decreased the amount of weight rats gained, impaired spatial learning and memory consolidation, and led to marked motor dysfunction. From our observations and analysis, PNB-0408 did not protect rats from the deficits induced by 3-NP neurotoxicity.

Limitations: Animal study only — human translation uncertain.

2024|Journal of Huntington's disease
PubMed

The sensory function in all nerve boundaries (peroneal, tibial, sural) returned to nearly normal by 8 weeks (Grade 2.7 on a scale of Grade 0-3 [0&#xa0;=&#xa0;No function; 3&#xa0;=&#xa0;Normal function]) in all groups combined. The peroneal nerve function recovered quickly with return of function at one week (&#x223c;2.0) while sural nerve function recovered rather slowly at four weeks (&#x223c;1.0).

Limitations: Animal study only — human translation uncertain.

2022|Annals of medicine and surgery (2012)
PubMed

We demonstrated that small-molecule cocktail CIP (including CHIR99021, IDE1, and PD0332991) efficiently induced definitive endoderm (DE) formation via increased endogenous TGF-&#x3b2;/Nodal signaling. Furthermore, we identified that combining Vitamin C, Dihexa, and Forskolin (VDF) could substitute growth factors to induce hepatic specification.

Limitations: No placebo control reported.

2022|Stem cell research &amp; therapy
PubMed

Of 450 articles identified, 32 met inclusion criteria. Seven of 11 studies of normal animals found Ang IV had beneficial effects on tests of passive or conditioned avoidance and object recognition.

Limitations: No placebo control reported. Review article — no new primary data.

2019|Neuroscience and biobehavioral reviews
PubMed

The protocol provides an efficient and reproducible procedure for differentiation of hPSCs into HLCs utilizing small molecules. &#xa9; 2016 by John Wiley & Sons, Inc.

Limitations: No placebo control reported.

2017|Current protocols in stem cell biology
PubMed

Dihexa is a first-in-class compound that is orally active, penetrates the blood-brain barrier, and facilitates memory consolidation and retrieval. This angiotensin-based small molecule may be efficacious as a treatment for AD.

Limitations: No placebo control reported. Review article — no new primary data.

2016|Journal of Alzheimer's disease : JAD
PubMed

Addition of an amino group to the N-terminal of Dihexa also attenuates the protective response, suggesting that even small substitutions greatly alter the specificity of Dihexa for its target. Our data suggest that Dihexa confers protection of hair cells through an HGF-mediated mechanism and that Dihexa holds clinical potential for mitigating chemical ototoxicity.

Limitations: Animal study only — human translation uncertain.

2015|Frontiers in cellular neuroscience
PubMed

These actions were inhibited by an HGF antagonist and a short hairpin RNA directed at c-Met. Most importantly, the procognitive/antidementia capacity of orally delivered dihexa was blocked by an HGF antagonist delivered intracerebroventricularly as measured using the Morris water maze task of spatial learning.

Limitations: No placebo control reported.

2014|The Journal of pharmacology and experimental therapeutics
PubMed

More striking, however, was the marked increase of kidney uptake of the dimers, explaining the unfavorable ratios. In conclusion, although radiolabeled alpha-MSH dimer peptides display excellent receptor affinity and internalization, they are no alternative to the monomeric DOTA-NAPamide for in vivo application.

Limitations: No placebo control reported.

2008|Journal of receptor and signal transduction research
PubMed

Community Outcomes

Community Data Coming Soon

Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!

Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.

Important Warnings

  • •NO human clinical trials - research use only
  • •Long-term safety completely unknown
  • •May promote angiogenesis (theoretical cancer concern)
  • •Extremely potent - dosing errors dangerous
Sourcing, Diagnostic Bloodwork & Telehealth Pathways

Where to get Dihexa, baseline labs & clinician oversight.

Full Dihexa $/mg comparison →
50% OFF AUTO-APPLIEDFrom $0.30/mg net

Ascension Peptides (US Vials)

MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.

MZ Biolabs COA (Grade A)Claim 50% Off
Verified Vial SuppliersGrade A COA

SwissChems & Limitless Biotech

Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).

LABS & 503A CLINICS$199/yr Labs · Rx Consult

Superpower Labs & 503A Telehealth

Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.

Code:SPAMBASSADOR

Where to buy Dihexa: best verified price

Prices checked Nov 11, 2026 · sorted by $/mg · RUO

  1. 1. Pure Peptides — $4.20/mg (10mg vial, $42.00)
  2. 2. Elite Research USA — $17.50/mg (10mg vial, $175.00)

Where is the cheapest place to buy Dihexa?

As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Pure Peptides at $4.20/mg (10mg vial, $42.00). We compared 2 US suppliers with live, checked prices.

How much does Dihexa cost per mg?

Verified US domestic prices currently range from $4.20/mg to $17.50/mg depending on supplier and vial size. Larger vials usually lower the $/mg.

How are these prices verified?

Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.

Is Dihexa approved for human use?

Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.

All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet

FREE 1-PAGE PDF CHEAT SHEET

Peptide Reconstitution & U-100 Syringe Cheat Sheet

Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.

Unsubscribe anytime.Direct PDF Download

Trusted Voices

X/Twitter accounts discussing this peptide

Related Peptides

Vendor vs vendor: price per mg

Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.

Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →

Common questions

How many peptides are in the database?

100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.

Where can I compare peptide prices?

Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.